Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c0982b0f02b1ed6d20a315370a3a3a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2854 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2851 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
filingDate |
2019-10-24^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-08-23^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_047cc71e458632eb80fddddf4d2761aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fa7fa937aa490140eeeabc5f11363e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d417b54f8137df2a9ae3949cf9bf2442 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc049cc24a5047cc9ea28327bd210329 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_929076e0e66793f71808dc87438cdbe8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16a6ed8ff631fabc74bbd244ede30309 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c3c613b4ba4f5b54eb7a7250b44707a |
publicationDate |
2022-08-23^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11421033-B2 |
titleOfInvention |
Insulin immunoglobulin fusion proteins |
abstract |
Disclosed herein are immunoglobulin fusion proteins comprising an insulin therapeutic peptide and an immunoglobulin region that targets the insulin therapeutic peptide to the liver of an individual in need thereof. Further disclosed herein are compositions comprising the immunoglobulin fusion proteins and methods for using the immunoglobulin fusion proteins for the treatment or prevention of a disease or condition in a subject, for example, diabetes and diabetes related conditions. |
priorityDate |
2015-09-04^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |